肺动脉瓣叶增补在法洛四联症经环修复中的中期结局
本研究评估了法洛四联症经环修复中肺动脉瓣叶增补的中期结果,纳入2007至2019年131例患者。中位随访6.25年,1年和5年免于重度肺动脉瓣反流分别为85%和76%,膨体聚四氟乙烯补片优于心包补片。
要点
- 经环修复联合肺动脉瓣叶增补术后中期重度肺动脉瓣反流发生率低于50%。
- 膨体聚四氟乙烯补片免于中度及以上肺动脉瓣反流优于心包补片。
- 术后需再干预(肺动脉瓣置换或球囊瓣膜成形)的比例较低。
核心结论
- 经环修复联合肺动脉瓣叶增补的中期随访中,重度肺动脉瓣反流发生率低于50%。
- 膨体聚四氟乙烯补片在免于中度及以上肺动脉瓣反流方面优于心包补片。
研究设计与样本
- 回顾性队列研究,纳入2007至2019年131例患者,其中法洛四联症120例,右室双出口伴肺动脉狭窄11例。
- 补片材料为膨体聚四氟乙烯76例、戊二醛处理自体心包47例、牛心包8例。
主要发现
- 修复中位年龄8.9个月(四分位距5.4-14.8),无手术死亡。
- 中位随访6.25年(四分位距2.77-7.75)。
- 1年和5年免于重度肺动脉瓣反流分别为85%(95%CI 77%-90%)和76%(95%CI 66%-83%)。
- 5年和10年免于中度及以上肺动脉瓣反流分别为69%(95%CI 60%-76%)和30%(95%CI 21%-39%)。
- 3例因肺动脉瓣反流行肺动脉瓣置换,9例因肺动脉瓣狭窄行球囊瓣膜成形;1年和5年免于肺动脉瓣狭窄干预分别为98%(95%CI 93%-99%)和94%(95%CI 87%-97%)。
关键数值与推荐
- 膨体聚四氟乙烯补片组免于中度及以上肺动脉瓣反流更优(log-rank检验P < .001;Cox回归风险比0.40,95%CI 0.25-0.63,P < .001)。
- 1例重度肺动脉瓣反流患者右室容积指数>160 mL/m2。
临床怎么用
- 经环修复法洛四联症时,采用肺动脉瓣叶增补可降低中期重度肺动脉瓣反流风险。
- 选择膨体聚四氟乙烯补片可能优于心包补片,以减少中度及以上肺动脉瓣反流。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the midterm results of pulmonary valve leaflet augmentation in transannular repair of tetralogy of Fallot (TOF). METHODS: From 2007 to 2019, 131 patients underwent a transannular repair with pulmonary leaflet augmentation for TOF (n = 120) and double outlet right ventricle with pulmonary stenosis (n = 11). Patch material was expanded polytetrafluoroethylene (n = 76), glutaraldehyde-treated autologous pericardium (n = 47) and bovine pericardium (n = 8). RESULTS: Median age at repair was 8.9 months (interquartile range, 5.4-14.8). There was no operative mortality. Median follow-up was 6.25 years (interquartile range, 2.77-7.75). Freedom from severe pulmonary regurgitation (PR) was 85% (95% confidence interval [CI], 77%-90%) and 76% (95% CI, 66%-83%) at 1 and 5 years, respectively. Freedom from moderate or greater PR was 69% (95% CI, 60%-76%) and 30% (95% CI, 21%-39%) at 5 and 10 years, respectively. Three patients required pulmonary valve replacement for PR. Nine patients required pulmonary balloon valvuloplasty. Freedom from intervention for pulmonary valve stenosis was 98% (95% CI, 93%-99%) and 94% (95% CI, 87%-97%) at 1 and 5 years, respectively. One patient with severe PR had an indexed right ventricular volume >160 mL/m2. Use of expanded polytetrafluoroethylene resulted in a greater freedom from moderate or greater PR (log-rank test P < .001; Cox regression hazard ratio, 0.40; 95% CI, 0.25-0.63; P < .001). CONCLUSIONS: At midterm follow-up of transannular repair with pulmonary valve leaflet augmentation, severe PR occurs in less than 50% of patients. The expanded polytetrafluoroethylene patch performs better than pericardium.
引用
- Patukale A, Daley M, Betts K, et al. Outcomes of pulmonary valve leaflet augmentation for transannular repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 2021. PMID: 33685734. doi:10.1016/j.jtcvs.2020.12.145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。